CDTX vs VFC · rev $1.3M vs P/E 26, rev $9.50B
Cidara Therapeutics Inc (CDTX) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
CDTX currently screens at market cap $6.96B. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the CDTX and VFC stock pages for the full models.
Not investment advice.